组合LIGHT过度表达和检查点阻塞破坏了瘤免疫环境,影响结直肠肝转移
Bridget P Keenan1, Guilin Qiao2, Nicholas Kunda3
1Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94143, USA.
Science advances
|October 8, 2025
概括
结合瘤亡因子超级家族成员14 (TNFSF14/LIGHT) 与抗细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 疗法,通过逆转T细胞枯竭和骨髓细胞抑制,消除结直肠肝转移. 这种免疫疗法组合显示出治疗耐药性肝癌的显著临床潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症转移 癌症转移
背景情况:
- 结肠直肠癌肝脏转移是癌症死亡的主要原因.
- 过度表达TNFSF14/LIGHT与更好的生存率和更多瘤透淋巴细胞相关.
- 光单疗可以激活T细胞,但也可以诱导T细胞疲劳和免疫抑制.
研究的目的:
- 研究结合LIGHT过度表达与对结直肠肝转移的抗CTLA-4疗法的疗效.
- 阐明组合疗法的抗瘤作用背后的机制.
- 评估这种组合在克服免疫疗法耐药性的临床相关性.
主要方法:
- 使用了结直肠肝转移的临床前模型.
- 服用轻度过度表达和/或抗CTLA-4疗法.
- 分析了T细胞激活,疲和瘤透的淋巴细胞.
- 评估了巨细胞群和瘤抗原特异性T细胞反应.
- 与补充患者队列相关联的发现.
主要成果:
- 光单一疗法激活了T细胞,但也导致了T细胞疲劳和免疫抑制.
- 通过LIGHT和抗CTLA-4的组合,可以完全控制瘤.
- 组合疗法增强了瘤透的淋巴细胞定位和诱导瘤抗原特异性T细胞.
- 这种组合逆转了T细胞耗尽,并消除了促进瘤的巨细胞.
- LIGHT和抗CTLA-4都增加了促进瘤的巨细胞,但组合消除了它们.
结论:
- 将LIGHT过度表达与抗CTLA-4治疗相结合,为结肠直肠肝转移中彻底消除瘤提供了一个强有力的策略.
- 这种组合克服了关键的免疫抑制机制,包括T细胞耗尽和骨髓细胞抑制.
- 这些发现对改善肝转移和其他对当前治疗抗性癌症的免疫疗法疗效具有重大临床意义.
更多相关视频
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
2.0K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K